Latigo Biotherapeutics, Inc.

CIK 2056611 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Latigo Biotherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 202610-Q0001193125-26-381969
Sep 3, 20268-K0001193125-26-381912
Aug 18, 2026SCHEDULE 13G0001193125-26-355798
Aug 17, 2026SCHEDULE 13D0001104659-26-097980
Aug 17, 2026SCHEDULE 13G0001346824-26-000233
Aug 13, 2026SCHEDULE 13G0001172661-26-003404
Aug 12, 202630001193125-26-345811
Aug 12, 202640001193125-26-345826
Aug 12, 202640001231919-26-000869
Aug 11, 202640001104659-26-093633
Aug 10, 20268-K0001193125-26-342321
Aug 10, 2026S-80001193125-26-342582
Aug 10, 202640001184592-26-000005
Aug 10, 202640001523672-26-000007
Aug 10, 202640001581754-26-000006
Aug 10, 202640001104659-26-093580
Aug 7, 2026424B40001193125-26-340329
Aug 6, 202630002144246-26-000002
Aug 6, 2026CERT0001354457-26-000763
Aug 6, 2026S-1MEF0001193125-26-338412
Aug 6, 202630001581754-26-000003
Aug 6, 202630001184592-26-000004
Aug 6, 202630001349376-26-000006
Aug 6, 202630001604019-26-000012
Aug 6, 202630001866171-26-000002